Kim Blackwell

Director at Fore Biotherapeutics.

Philadelphia, PA
Fore Biotherapeutics

Raised on Fore Biotherapeutics filings

$70.4M

of $109.6M offered across 1 Form D filing

Form D filings: 1
Teammates: 1
Last filing: Jul 14, 2026

Company

Fore Biotherapeutics

Biotech · Philadelphia, PA

BRAF inhibitor for brain and solid tumors

BRAF inhibitor for brain and solid tumors

Investors: 20
Founded: 2022
Still open: $39.2M

Investors: 20
Sector: Biotech
Founded: 2022
HQ: Philadelphia, PA

Fore Biotherapeutics filings

Fore Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 14, 2026	Equity	$70.4M/ $109.6M	Form D/A

EquityFiled Jul 14, 2026Form D/A
$70.4M/ $109.6M

Works with

Also named on Fore Biotherapeutics filings

Michael ByrnesChief Financial Officer, Form D signerForm D signer